tiprankstipranks
Trending News
More News >
Bodal Chemicals Limited (IN:BODALCHEM)
:BODALCHEM
India Market
Advertisement

Bodal Chemicals Limited (BODALCHEM) AI Stock Analysis

Compare
0 Followers

Top Page

IN:BODALCHEM

Bodal Chemicals Limited

(BODALCHEM)

Rating:52Neutral
Price Target:
₹72.00
▲(9.86% Upside)
Bodal Chemicals' overall stock score is primarily influenced by its financial performance and technical analysis. The company shows strong revenue growth and operational efficiency but faces challenges with profitability and free cash flow. Technical indicators point to potential weakness in the short term. Valuation metrics suggest the stock is overvalued, impacting the overall score negatively.

Bodal Chemicals Limited (BODALCHEM) vs. iShares MSCI India ETF (INDA)

Bodal Chemicals Limited Business Overview & Revenue Model

Company DescriptionBodal Chemicals Limited is a prominent chemical manufacturing company headquartered in India. It operates primarily in the chemical sector, focusing on the production of dye intermediates, dyestuffs, and basic chemicals. The company's comprehensive product range serves various industries, including textiles, leather, and paper.
How the Company Makes MoneyBodal Chemicals Limited generates revenue through the manufacturing and sale of a wide array of chemical products. The company's primary revenue streams include the production and distribution of dye intermediates, which are essential components in the textile industry for dye production. Additionally, Bodal Chemicals produces dyestuffs that are used directly by textile manufacturers. The company also offers basic chemicals utilized across multiple industries, thereby diversifying its revenue base. Strategic partnerships and collaborations with key industry players further enhance its market reach and profitability. Moreover, Bodal Chemicals leverages its extensive distribution network to supply products both domestically and internationally, contributing significantly to its earnings.

Bodal Chemicals Limited Financial Statement Overview

Summary
Bodal Chemicals demonstrates positive revenue growth and improved operational efficiencies, with rising gross and EBIT margins. However, low profitability with a net profit margin of 1.06% and negative free cash flow are concerns for long-term sustainability. The balance sheet is stable with a strong equity position and manageable debt levels.
Income Statement
65
Positive
Bodal Chemicals has shown a mixed performance in its income statement. The company experienced a solid revenue growth rate of 25.12% from the previous year to 2025. However, its net profit margin is relatively low at 1.06%, reflecting challenges in converting revenues into profits. The gross profit margin improved significantly to 38.71% in 2025, indicating better cost management. The EBIT margin of 5.65% also shows a positive trend from prior years, suggesting operational efficiency improvements. Despite these positives, the low net profit margin remains a concern.
Balance Sheet
70
Positive
The balance sheet reveals a stable financial structure for Bodal Chemicals. The debt-to-equity ratio stands at 0.82, indicating a balanced approach to leveraging. The company's equity ratio of 46.94% suggests a strong equity base, although there is room for improvement. Return on equity (ROE) is low at 1.67%, highlighting inefficiencies in generating profits from equity. Overall, Bodal Chemicals maintains a stable financial position with manageable debt levels.
Cash Flow
55
Neutral
The cash flow statement shows Bodal Chemicals facing challenges in generating free cash flow, with a negative free cash flow in 2025. The operating cash flow to net income ratio is positive at 2.06, indicating that the company generates more cash than accounting profits, which is a positive sign. However, the negative free cash flow growth rate from 2024 to 2025 reflects ongoing capital expenditure pressures. The free cash flow to net income ratio is negative, pointing to potential liquidity issues if not addressed.
BreakdownTTMDec 2025Dec 2024Dec 2022Dec 2022Dec 2021
Income Statement
Total Revenue16.88B17.45B13.95B20.27B15.74B12.21B
Gross Profit7.35B6.76B1.68B5.42B6.70B3.29B
EBITDA1.50B1.69B1.19B2.18B1.45B1.03B
Net Income60.39M185.02M64.69M1.04B380.33M419.82M
Balance Sheet
Total Assets0.0023.53B22.88B21.22B21.21B17.48B
Cash, Cash Equivalents and Short-Term Investments228.86M360.60M462.50M93.95M225.87M119.14M
Total Debt0.009.11B8.47B5.76B6.98B3.47B
Total Liabilities-10.83B12.48B12.06B10.70B10.43B7.68B
Stockholders Equity10.83B11.05B10.82B10.56B10.78B9.75B
Cash Flow
Free Cash Flow0.00-83.36M-407.19M-1.73B-528.49M-1.91B
Operating Cash Flow0.00381.14M2.04B-135.20M2.85B-130.17M
Investing Cash Flow0.00-424.34M-2.62B-1.70B-3.10B-1.68B
Financing Cash Flow0.0076.36M809.81M1.81B326.55M1.78B

Bodal Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price65.54
Price Trends
50DMA
72.29
Negative
100DMA
71.31
Negative
200DMA
68.44
Negative
Market Momentum
MACD
-2.15
Positive
RSI
37.78
Neutral
STOCH
20.47
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BODALCHEM, the sentiment is Negative. The current price of 65.54 is below the 20-day moving average (MA) of 67.20, below the 50-day MA of 72.29, and below the 200-day MA of 68.44, indicating a bearish trend. The MACD of -2.15 indicates Positive momentum. The RSI at 37.78 is Neutral, neither overbought nor oversold. The STOCH value of 20.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BODALCHEM.

Bodal Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹8.67B18.62
0.77%25.56%92.57%
65
Neutral
₹10.18B15.20
0.48%16.35%55.54%
63
Neutral
₹11.89B13.43
0.38%3.65%-25.64%
61
Neutral
$10.24B6.180.71%2.90%3.45%-36.02%
61
Neutral
₹29.46B15.54
-12.76%-17.97%
54
Neutral
₹10.22B109.92
0.96%-19.46%-80.73%
52
Neutral
₹8.12B27.93
0.17%19.75%844.66%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BODALCHEM
Bodal Chemicals Limited
65.54
-18.06
-21.60%
IN:AGARIND
Agarwal Industrial Corporation Limited
805.55
-434.89
-35.06%
IN:BHAGERIA
Bhageria Industries Ltd.
198.70
-38.57
-16.26%
IN:FAIRCHEMOR
Fairchem Organics Ltd
782.40
-486.76
-38.35%
IN:KIRIINDUS
Kiri Industries Limited
525.80
133.95
34.18%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
314.15
67.46
27.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 02, 2025